Published in
American Chemical Society, Journal of Medicinal Chemistry, 17(63), p. 9300-9315, 2020
DOI: 10.1021/acs.jmedchem.0c00451
Links
Tools
Development of potent PfCLK3 inhibitors based on TCMDC-135051 as a new class of antimalarials
Journal article published in 2020 by
Amit Mahindra,
Omar Janha,
Kopano Mapesa,
Ana Sanchez Azqueta,
Ana Sanchez-Azqueta,
Mahmood M. Alam 
,
Alfred Amambua-Ngwa,
Davies C. Nwakanma,
Andrew B. Tobin ,
Andrew G. Jamieson
,
Alfred Amambua-Ngwa,
Davies C. Nwakanma,
Andrew B. Tobin ,
Andrew G. Jamieson
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving allowed
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Postprint:
archiving restricted
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Published version:
archiving forbidden
Data provided by 